Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review.
about
The role of concomitant extracorporeal photopheresis for the treatment of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantationThe role of concomitant extracorporeal photopheresis for the treatment of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantationTherapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic StrategiesIL-7 in allogeneic transplant: clinical promise and potential pitfallsGenetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donorsAminoglycoside-free interventional antibiotic management in patients undergoing haemopoietic stem cell transplantation.Pediatric hematopoietic stem cell transplantation in China: Data and trends during 1998-2012.Mesenchymal stromal cells: a new tool against graft-versus-host disease?Prevention of graft-versus-host disease by anti IL-7Ralpha antibody.Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host DiseaseInfluence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation.Thinking out of the box--new approaches to controlling GVHD.Lipid-based delivery of CpG oligodeoxynucleotides for cancer immunotherapy.MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation.Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time.Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations.Protein dysregulation in graft versus host disease.Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease.Mucositis after reduced intensity conditioning and allogeneic stem cell transplantation.First Successful Haploidentical Stem Cell Transplantation in Romania.
P2860
Q24186279-6BDA5B7D-0CC0-4A7F-9C3F-CA193B6B910EQ24198004-F4ECA822-4B3A-484C-BDCF-F02320123F5CQ26751959-FABD42D1-6992-403A-BC0D-B93CE77242F3Q28259144-E132BE7B-DD31-44B4-8561-03C0339DF0E5Q33747297-D6E0EB93-4827-409B-85B6-8C4E36A679D3Q34180913-B2D94632-4CE3-4562-987D-B00A2628ABC5Q35658742-38BFE8C9-5D47-4A22-9026-AB216FA323EEQ35848391-F26ED791-896C-4F4D-AE99-ADAA26A2090FQ36059590-040E7AAB-3390-40F2-A727-DD3D6CA431E9Q36220062-5D4B47D6-331F-4462-9558-F85495C87AFBQ36474050-4241FE67-6832-4018-8470-97F12BA07F01Q37618811-15C3154F-4D78-4441-A5D6-499713DEE7CAQ38105635-AD9DF23D-CF78-4CC7-9424-2E175193DC3FQ38175862-EF036B56-C648-4FCE-A23E-221C2A50D385Q38177364-53651F22-BD5D-47C4-8BC5-8D325993CA4DQ38434710-624B3208-D410-41F6-8C39-8EC7FB8CB73AQ38472178-7CAE51D0-58C0-406B-869B-55197C2E7EA3Q38816505-50028B57-12E8-4086-A355-840E4C022ADFQ38995756-CB40623D-7B96-4B1F-A74D-FE084E965EA0Q39157279-CFCEDF66-3375-4E8E-B0F5-82AC2244F8A8Q49228781-BC8F9AB8-A50F-4ED8-B18B-966B31DD802EQ50489657-3713B434-C7DD-4988-A703-EC4F985D889DQ51404076-E05DACC4-7EB2-4148-8D49-1C7261A9FE54Q51798540-A491E9F1-0900-48E0-BA78-968AF4B4391F
P2860
Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Allogeneic hematopoietic cell ...... ogical malignancies: a review.
@ast
Allogeneic hematopoietic cell ...... ogical malignancies: a review.
@en
type
label
Allogeneic hematopoietic cell ...... ogical malignancies: a review.
@ast
Allogeneic hematopoietic cell ...... ogical malignancies: a review.
@en
prefLabel
Allogeneic hematopoietic cell ...... ogical malignancies: a review.
@ast
Allogeneic hematopoietic cell ...... ogical malignancies: a review.
@en
P1476
Allogeneic hematopoietic cell ...... ogical malignancies: a review.
@en
P2093
Frédéric Baron
P2888
P356
10.1007/S00281-004-0165-3
P577
2004-07-29T00:00:00Z